Results 161 to 170 of about 7,998 (203)

Generation of two iPSC lines from patients with Aicardi-Goutières syndrome carrying either biallelic ADAR1 mutations (PC138) or a heterozygous IFIH1 mutation (PC139). [PDF]

Stem Cell Res
Zerad L, Didry-Barca B, Banal C, Onteniente B, Lefort N, Lepelley A, Seabra L, Hully M, Zweier C, Bondurand N, Crow YJ, Frémond ML.   +11 more
europepmc   +1 more source

Deaminase Modulation Driving a New Era in Drug Development. [PDF]

Int J Mol Sci
Lindley RA.
europepmc   +1 more source

Epitranscriptome-wide profiling identifies RNA editing events regulated by ADAR1 that are associated with DNA repair mechanisms in human TK6 cells. [PDF]

Front Genet
Yoshida A, Song Y, Takaine H, Song S, Konishi N, Hwang-Fu YH, Johnson Z, Ura K, Sassa A.   +8 more
europepmc   +1 more source

Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. [PDF]

Front Immunol
Chen Z, Hu R, Ye H, Chen Q, Liu Y, Zhang X, Chen Y, Wu Y, Jin C.   +8 more
europepmc   +1 more source

PACT suppresses PKR activation through dsRNA binding and dimerization, and is a therapeutic target for triple-negative breast cancer. [PDF]

RNA
Young AA, Juhler IG, Pierce JR, Bohlin HE, Harper HA, Onishile DS, Chua RN, Liu ME, Gardner EN, Elzey BD, Cottrell KA.   +10 more
europepmc   +1 more source

MYC drives left-handed Z-DNA formation to shape gene expression. [PDF]

Nat Commun
Wan X, Fan H, Li Z, Du Y, Liu Y, Zeng W, Sun Z, Shao J, Jia J, Zhang Y, Fang D.   +10 more
europepmc   +1 more source

Cromolyn as a novel pharmacophore of the Zα domain of the RNA-editing enzyme ADAR1p150. [PDF]

Protein Sci
Langdon N, Kroft C, Fang Q, Krall J, Rincon M, Vögeli B, Vicens Q, Henen MA.   +7 more
europepmc   +1 more source

Clinical insight-driven novel drug development: Multidisciplinary integration and transformative opportunities. [PDF]

Acta Pharm Sin B
Li B, Xu H, Shi X, Ma C, Yang J, Zhan P.
europepmc   +1 more source

A hepatitis B virus RNA-sensing and RNA-editing-dependent reporter system. [PDF]

J Virol
Sun L, Snedeker A, Tang L.
europepmc   +1 more source

Mouse models of type I interferonopathies. [PDF]

Hum Mol Genet
Luca D, Kato H.
europepmc   +1 more source